Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
Comprehensive Psychiatry|July 6, 2025
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyLuca Pellegrini, Naomi A Fineberg, Sorcha O'Connor, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 20, 2025
A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of ConsciousnessNaji L N Alnagger, Paolo Cardone, Charlotte Martial, et al.
Journal of Psychopharmacology (Oxford, England)|June 16, 2020
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experimentAnna Borissova, Bart Ferguson, Matthew B Wall, et al.
Addiction Biology|July 26, 2018
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk levelWim van den Brink, Giovanni Addolorato, Henri-Jean Aubin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2010
Manifesto for a European anxiety disorders research networkDavid S Baldwin, Christer Allgulander, Alfredo Carlo Altamura, et al.
World Journal of Psychiatry|April 10, 2023
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statementSusan Young, Cyrus Abbasian, Zainab Al-Attar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
Comprehensive Psychiatry|July 6, 2025
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyLuca Pellegrini, Naomi A Fineberg, Sorcha O'Connor, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 20, 2025
A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of ConsciousnessNaji L N Alnagger, Paolo Cardone, Charlotte Martial, et al.
Journal of Psychopharmacology (Oxford, England)|June 16, 2020
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experimentAnna Borissova, Bart Ferguson, Matthew B Wall, et al.
Addiction Biology|July 26, 2018
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk levelWim van den Brink, Giovanni Addolorato, Henri-Jean Aubin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2010
Manifesto for a European anxiety disorders research networkDavid S Baldwin, Christer Allgulander, Alfredo Carlo Altamura, et al.
World Journal of Psychiatry|April 10, 2023
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statementSusan Young, Cyrus Abbasian, Zainab Al-Attar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Pageof 18